Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease

Alzheimer’s disease (AD) is a burgeoning social and healthcare problem. Cholinesterase inhibitors (ChEIs) are employed for symptomatic treatment of AD, but often elicit adverse drug reactions (ADRs). Herein, the potency of the ChEIs, donepezil, tacrine, berberine, and galantamine to inhibit human or...

Descripción completa

Detalles Bibliográficos
Autores principales: Amat-ur-Rasool, Hafsa, Ahmed, Mehboob, Hasnain, Shahida, Carter, Wayne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913148/
https://www.ncbi.nlm.nih.gov/pubmed/33540879
http://dx.doi.org/10.3390/brainsci11020184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913148/
https://www.ncbi.nlm.nih.gov/pubmed/33540879
http://dx.doi.org/10.3390/brainsci11020184

Ejemplares similares